Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.
about
Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteinsMolding BRCA2 function through its interacting partnersTwo decades after BRCA: setting paradigms in personalized cancer care and preventionBRCA2 regulates DMC1-mediated recombination through the BRC repeats.Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern PolandScreening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.Functional assays for analysis of variants of uncertain significance in BRCA2.Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.Hereditary breast and ovarian cancer: new genes in confined pathways.Acquired cross-linker resistance associated with a novel spliced BRCA2 protein variant for molecular phenotyping of BRCA2 disruption.Exceptions to the rule: case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes.Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches.Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes.Capillary electrophoresis analysis of conventional splicing assays: IARC analytical and clinical classification of 31 BRCA2 genetic variants.Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population.
P2860
Q27308072-A7E93C32-5233-4132-8786-7C156916F392Q28085364-00C0E385-C8D2-4511-8070-4CED9164F070Q28085603-C2507BEA-1DD6-43EB-8818-3519FFBF8BC4Q33820594-2CD7B3A2-39D9-4FF8-BD9D-134A0530DD07Q34518167-EF065F57-C739-4603-9102-E383354CF6E6Q36538025-987D059F-CEB8-4F92-B197-362E7D357C1BQ37011944-80E9B889-92DA-4646-8E49-AEDFA765E686Q37715826-A83FB2B8-20E2-4FC6-BB92-43AEE0FB4636Q38685850-171AE83C-F3E6-4218-8385-458401E51E7FQ38914005-48A1E568-6258-4426-B002-2D456942C678Q38925408-70889900-94DD-4AB9-AB72-D2D7A6FB0ED3Q41084246-41D240FD-CE9F-4C0E-8EF5-11855027310CQ41499215-75C821C6-1E3D-4152-BCDE-09300F74BC0DQ50210067-A1C16488-B77A-4706-9BA8-9DE8B1498B89Q51062318-A9C1A24C-8C40-4581-B1A6-A14A17FD1B95Q53101648-8DB73CC4-BF3F-473F-9F68-95D78BF29EDBQ53310020-59CAF526-0636-408E-9A9C-04954A01316BQ55280273-3FD6CC50-B4E4-4825-B594-2F12DE1BA339
P2860
Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Functional evaluation of BRCA2 ...... g a mouse ES cell-based assay.
@ast
Functional evaluation of BRCA2 ...... g a mouse ES cell-based assay.
@en
type
label
Functional evaluation of BRCA2 ...... g a mouse ES cell-based assay.
@ast
Functional evaluation of BRCA2 ...... g a mouse ES cell-based assay.
@en
prefLabel
Functional evaluation of BRCA2 ...... g a mouse ES cell-based assay.
@ast
Functional evaluation of BRCA2 ...... g a mouse ES cell-based assay.
@en
P2093
P2860
P356
P1476
Functional evaluation of BRCA2 ...... ng a mouse ES cell-based assay
@en
P2093
Benjamin B Roa
Betty K Martin
Dmitry Pruss
Eileen Southon
Huanyu Qiao
Julie M Eggington
Kajal Biswas
Karla R Bowles
Lino Tessarollo
Neil Hunter
P2860
P304
P356
10.1093/HMG/DDS222
P577
2012-06-07T00:00:00Z